This is the first direct observation of a hydroxyl-hydronium complex – important for a wide range of chemical and biological processes from the tails of comets to cancer treatment.

SLAC and Stanford scientists used it to zoom in on an iconic RNA catalyst and a piece of viral RNA that’s a potential target for COVID-19 treatments.

SSRL and LCLS scientists will help visiting research teams solve their experimental challenges, then apply what they’ve learned to help others work more efficiently.

Stanford EM-X brings hundreds of researchers around the world together to discuss the latest methods and discoveries from electron microscopes.

G6PD deficiency affects about 400M people worldwide and can pose serious health risks. Uncovering the causes of the most severe cases could finally lead to treatments.

Researchers at Stanford are working to develop a single-dose vaccine for SARS-CoV-2 that could potentially be stored at room temperature.

The study, done on a mild-mannered relative of the virus that causes COVID-19, paves the way for seeing more clearly how spike proteins initiate infections, with an eye to preventing and treating them.

The lab’s X-ray laser recently joined other facilities in making remote science possible from any corner of the world, a trend that will likely continue into the future.

No human cell can function without these tiny machines, which cause disease when they go haywire and offer potential targets for therapeutic drugs.

They found that gently heating N95 masks in high relative humidity could inactivate SARS-CoV-2 virus trapped within the masks, without degrading the masks’ performance.

Using SLAC’s synchrotron, Summers improves fundamental knowledge of the role of copper in the brain and investigates treatments for Alzheimer’s disease.

Stanford and SLAC scientists studying the varicella zoster virus found that an antibody that blocks infection doesn’t work exactly as they’d thought.